Font size
Color
Home
Services
Mission Area
Industry and Investment Strategy
Pharmaceuticals & Regenerative Medicine
Advanced Medical Devices Technology & Medical Robotics
Nutraceuticals and Cosmeceuticals
Innovation Utilization for Socioeconomics
APEC Life Sciences
The Southeast ASIA-Europe Joint Funding Scheme on Research and Innovation (JFS)
Data Resources
Technology Trends Analysis
Investment Regulation and Incentives
Market Statistic Analysis
Business and Investment News
หนังสืออิเล็กทรอนิกส์
Thailand Life Sciences
Thai Clinical Trials Registry (TCTR)
CSDT e-Learning
CSDT e-Learning
Database of Essential Principle (Eps) and National Quality Infrastructure (NQI) for Medical Devices
E-Document System for CSDT
Genomics
News
Coming Soon
Press Release
Event Calendar
Purchase
Procurement
Join us
Jobs
Results Announcement
VDO
About TCELS
Overview
Organizational Structure
Executive Committee and TCELS Executives
Our Partners
Our Partners
Contact Us
search
© ศลช. 2018, All right reserved
EN
TH
Data Resources
>
Investment Regulation and Incentives
>
Regulatory revisions for cell therapy in Canada.
Regulatory revisions for cell therapy in Canada.
11/09/2020
Nowadays, cell therapy is continuously progressing to reach its potential. The therapy aims to improve the quality of life of healthy people, and the treatment of severe rare diseases. However, given the complexity and ongoing development of cell therapy, in 2019 the Canadian government revised the regulations on cell therapy to emphasize the safety of patients, the effectiveness of treatment, and importantly the promotion of industrial development.
Please fill the following information to continue reading.
Email
Page view :
77